Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction

Zeinab Berangi1, Manoochehr Karami2,3, Younes Mohammadi4

  • 1Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, 65178-3-8736, Iran.

BMC Pediatrics
|October 24, 2019
PubMed
Abstract

Insights

This study analyzed meningitis cases in Iran from 2008-2014, finding a decreasing incidence trend. Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis were the primary bacterial causes, predominantly affecting young children.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Limited comprehensive studies on meningitis epidemiology in Iran pre-2014.
  • The period studied precedes the introduction of pneumococcal conjugate vaccine (PCV) and pentavalent vaccine.

Purpose of the Study:

  • To describe the epidemiological profile of meningitis in Iran.
  • To analyze meningitis incidence and trends from 2008 to 2014.

Main Methods:

  • Utilized data from Iran's national notifiable diseases surveillance system.
  • Included 1352 confirmed meningitis cases aged 1 day to 110 years.
  • Extracted data from March 2008 to December 2014.

Main Results:

  • Meningitis incidence decreased from 0.28/100,000 in 2008 to 0.09/100,000 in 2014.
  • Key pathogens were Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, all showing descending trends.
  • The majority of cases occurred in children under five, with a male predominance.

Conclusions:

  • Despite decreasing trends, PCV introduction is recommended by WHO.
  • Enhanced surveillance is crucial for high-quality meningitis data in Iran.
  • High rates of negative cultures warrant further investigation into diagnostic methods.